Logo image of IRBT

IROBOT CORP (IRBT) Stock Fundamental Analysis

USA - NASDAQ:IRBT - US4627261005 - Common Stock

4.115 USD
-0.12 (-2.95%)
Last: 9/23/2025, 10:47:57 AM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to IRBT. IRBT was compared to 63 industry peers in the Household Durables industry. Both the profitability and financial health of IRBT have multiple concerns. While showing a medium growth rate, IRBT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year IRBT has reported negative net income.
In the past year IRBT has reported a negative cash flow from operations.
In multiple years IRBT reported negative net income over the last 5 years.
IRBT had negative operating cash flow in 4 of the past 5 years.
IRBT Yearly Net Income VS EBIT VS OCF VS FCFIRBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M -300M

1.2 Ratios

IRBT's Return On Assets of -40.30% is on the low side compared to the rest of the industry. IRBT is outperformed by 95.24% of its industry peers.
Industry RankSector Rank
ROA -40.3%
ROE N/A
ROIC N/A
ROA(3y)-34.67%
ROA(5y)-17.81%
ROE(3y)-150.96%
ROE(5y)-86.07%
ROIC(3y)N/A
ROIC(5y)N/A
IRBT Yearly ROA, ROE, ROICIRBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

IRBT's Gross Margin of 24.26% is on the low side compared to the rest of the industry. IRBT is outperformed by 61.90% of its industry peers.
IRBT's Gross Margin has declined in the last couple of years.
IRBT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.94%
GM growth 5Y-13.55%
IRBT Yearly Profit, Operating, Gross MarginsIRBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

0

2. Health

2.1 Basic Checks

IRBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IRBT has more shares outstanding
IRBT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, IRBT has a worse debt to assets ratio.
IRBT Yearly Shares OutstandingIRBT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
IRBT Yearly Total Debt VS Total AssetsIRBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -0.98, we must say that IRBT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of IRBT (-0.98) is worse than 90.48% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.98
ROIC/WACCN/A
WACC11.37%
IRBT Yearly LT Debt VS Equity VS FCFIRBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.54 indicates that IRBT may have some problems paying its short term obligations.
The Current ratio of IRBT (0.54) is worse than 96.83% of its industry peers.
A Quick Ratio of 0.34 indicates that IRBT may have some problems paying its short term obligations.
IRBT has a Quick ratio of 0.34. This is amonst the worse of the industry: IRBT underperforms 88.89% of its industry peers.
Industry RankSector Rank
Current Ratio 0.54
Quick Ratio 0.34
IRBT Yearly Current Assets VS Current LiabilitesIRBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 47.72% over the past year.
Looking at the last year, IRBT shows a very negative growth in Revenue. The Revenue has decreased by -26.60% in the last year.
Measured over the past years, IRBT shows a very negative growth in Revenue. The Revenue has been decreasing by -10.90% on average per year.
EPS 1Y (TTM)47.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.22%
Revenue 1Y (TTM)-26.6%
Revenue growth 3Y-24.19%
Revenue growth 5Y-10.9%
Sales Q2Q%-23.32%

3.2 Future

Based on estimates for the next years, IRBT will show a very strong growth in Earnings Per Share. The EPS will grow by 33.99% on average per year.
Based on estimates for the next years, IRBT will show a quite strong growth in Revenue. The Revenue will grow by 9.89% on average per year.
EPS Next Y35.33%
EPS Next 2Y33.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-28.71%
Revenue Next 2Y9.89%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IRBT Yearly Revenue VS EstimatesIRBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
IRBT Yearly EPS VS EstimatesIRBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 4 -4 -6 -8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IRBT. In the last year negative earnings were reported.
Also next year IRBT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IRBT Price Earnings VS Forward Price EarningsIRBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IRBT Per share dataIRBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

IRBT's earnings are expected to grow with 33.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.99%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IRBT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IROBOT CORP

NASDAQ:IRBT (9/23/2025, 10:47:57 AM)

4.115

-0.12 (-2.95%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-03 2025-11-03
Inst Owners54.26%
Inst Owner Change-18.79%
Ins Owners3.43%
Ins Owner Change18.48%
Market Cap129.09M
Analysts43.33
Price Target11.22 (172.66%)
Short Float %25.81%
Short Ratio4.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.92%
Min EPS beat(2)-50.53%
Max EPS beat(2)76.37%
EPS beat(4)2
Avg EPS beat(4)40.2%
Min EPS beat(4)-50.53%
Max EPS beat(4)152.06%
EPS beat(8)4
Avg EPS beat(8)16.02%
EPS beat(12)5
Avg EPS beat(12)-79.34%
EPS beat(16)8
Avg EPS beat(16)-43.84%
Revenue beat(2)1
Avg Revenue beat(2)-10.15%
Min Revenue beat(2)-20.34%
Max Revenue beat(2)0.05%
Revenue beat(4)1
Avg Revenue beat(4)-10.05%
Min Revenue beat(4)-20.34%
Max Revenue beat(4)0.05%
Revenue beat(8)2
Avg Revenue beat(8)-8.73%
Revenue beat(12)3
Avg Revenue beat(12)-12.03%
Revenue beat(16)4
Avg Revenue beat(16)-10.45%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)28.57%
EPS NY rev (1m)0%
EPS NY rev (3m)-30.84%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.33%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-23.91%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.22
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.25
EYN/A
EPS(NY)-1.13
Fwd EYN/A
FCF(TTM)-2.22
FCFYN/A
OCF(TTM)-2.22
OCFYN/A
SpS18.95
BVpS-0.25
TBVpS-6.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -40.3%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.26%
FCFM N/A
ROA(3y)-34.67%
ROA(5y)-17.81%
ROE(3y)-150.96%
ROE(5y)-86.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.94%
GM growth 5Y-13.55%
F-Score3
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.54
Quick Ratio 0.34
Altman-Z -0.98
F-Score3
WACC11.37%
ROIC/WACCN/A
Cap/Depr(3y)11.65%
Cap/Depr(5y)43.11%
Cap/Sales(3y)0.46%
Cap/Sales(5y)1.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.22%
EPS Next Y35.33%
EPS Next 2Y33.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-26.6%
Revenue growth 3Y-24.19%
Revenue growth 5Y-10.9%
Sales Q2Q%-23.32%
Revenue Next Year-28.71%
Revenue Next 2Y9.89%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y16.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year117.97%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-344.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-281.27%
OCF growth 3YN/A
OCF growth 5YN/A